Cargando…
Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy
BACKGROUND: Inflammatory response and nutritional status are associated with cancer development and progression. The purpose of this study was to explore whether the preoperative fibrinogen-albumin ratio index (FARI) is related to prognosis and chemoradiotherapy outcome of radical surgery after neoa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505706/ https://www.ncbi.nlm.nih.gov/pubmed/32982448 http://dx.doi.org/10.2147/CMAR.S273065 |
_version_ | 1783584870242451456 |
---|---|
author | Lu, Siyi Liu, Zhenzhen Zhou, Xin Wang, Bingyan Li, Fei Ma, Yanpeng Wang, Wendong Ma, Junren Wang, Yuxia Wang, Hao Fu, Wei |
author_facet | Lu, Siyi Liu, Zhenzhen Zhou, Xin Wang, Bingyan Li, Fei Ma, Yanpeng Wang, Wendong Ma, Junren Wang, Yuxia Wang, Hao Fu, Wei |
author_sort | Lu, Siyi |
collection | PubMed |
description | BACKGROUND: Inflammatory response and nutritional status are associated with cancer development and progression. The purpose of this study was to explore whether the preoperative fibrinogen-albumin ratio index (FARI) is related to prognosis and chemoradiotherapy outcome of radical surgery after neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced rectal cancer (LARC). METHODS: In total, 123 patients with LARC who underwent radical surgery after NCRT between June 2012 and December 2018 were collected in this study. Time-dependent receiver operating characteristic (ROC) curve analysis was made to evaluate the ability of the markers for forecasting prognosis. The correlation between FARI and clinicopathological parameters was analyzed. The Kaplan–Meier survival analysis, univariate and multivariate analysis based on Cox proportional hazards models, and subgroup analysis were performed to evaluate overall survival (OS) and disease-free survival (DFS). A nomogram was constructed to evaluate the predictive role of FARI in DFS. RESULTS: The ROC curve analysis showed that the ability of FARI on DFS prediction was superior to those of other inflammatory markers and carcinoembryonic antigen (CEA) (P<0.05). Based on the Youden’s index, the optimal cut-off value of FARI was 8.8%. High FARI patients (>8.8%) showed a poor response to NCRT and a decreased DFS rate (P<0.05). In addition, multivariate analysis revealed that FARI (HR=3.098, P=0.033), neutrophil-to-lymphocyte ratio (NLR), and postoperative T stage were independent prognostic factors for DFS in TNM stage III LARC patients. However, FARI failed to distinguish patients with poor OS. Harrell’s concordance index (C-index) of the nomogram containing FARI (0.807) was obviously higher than that without it (0.732) among LARC patients who underwent radical surgery after NCRT. Moreover, multivariate analysis revealed FARI (OR=3.044, P=0.012) as an independent predictor for response to NCRT. CONCLUSION: Among LARC patients who underwent radical surgery after NCRT, preoperative FARI is an independent prognostic factor for DFS and an independent predictor for response to NCRT. |
format | Online Article Text |
id | pubmed-7505706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75057062020-09-24 Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy Lu, Siyi Liu, Zhenzhen Zhou, Xin Wang, Bingyan Li, Fei Ma, Yanpeng Wang, Wendong Ma, Junren Wang, Yuxia Wang, Hao Fu, Wei Cancer Manag Res Original Research BACKGROUND: Inflammatory response and nutritional status are associated with cancer development and progression. The purpose of this study was to explore whether the preoperative fibrinogen-albumin ratio index (FARI) is related to prognosis and chemoradiotherapy outcome of radical surgery after neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced rectal cancer (LARC). METHODS: In total, 123 patients with LARC who underwent radical surgery after NCRT between June 2012 and December 2018 were collected in this study. Time-dependent receiver operating characteristic (ROC) curve analysis was made to evaluate the ability of the markers for forecasting prognosis. The correlation between FARI and clinicopathological parameters was analyzed. The Kaplan–Meier survival analysis, univariate and multivariate analysis based on Cox proportional hazards models, and subgroup analysis were performed to evaluate overall survival (OS) and disease-free survival (DFS). A nomogram was constructed to evaluate the predictive role of FARI in DFS. RESULTS: The ROC curve analysis showed that the ability of FARI on DFS prediction was superior to those of other inflammatory markers and carcinoembryonic antigen (CEA) (P<0.05). Based on the Youden’s index, the optimal cut-off value of FARI was 8.8%. High FARI patients (>8.8%) showed a poor response to NCRT and a decreased DFS rate (P<0.05). In addition, multivariate analysis revealed that FARI (HR=3.098, P=0.033), neutrophil-to-lymphocyte ratio (NLR), and postoperative T stage were independent prognostic factors for DFS in TNM stage III LARC patients. However, FARI failed to distinguish patients with poor OS. Harrell’s concordance index (C-index) of the nomogram containing FARI (0.807) was obviously higher than that without it (0.732) among LARC patients who underwent radical surgery after NCRT. Moreover, multivariate analysis revealed FARI (OR=3.044, P=0.012) as an independent predictor for response to NCRT. CONCLUSION: Among LARC patients who underwent radical surgery after NCRT, preoperative FARI is an independent prognostic factor for DFS and an independent predictor for response to NCRT. Dove 2020-09-17 /pmc/articles/PMC7505706/ /pubmed/32982448 http://dx.doi.org/10.2147/CMAR.S273065 Text en © 2020 Lu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Lu, Siyi Liu, Zhenzhen Zhou, Xin Wang, Bingyan Li, Fei Ma, Yanpeng Wang, Wendong Ma, Junren Wang, Yuxia Wang, Hao Fu, Wei Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy |
title | Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy |
title_full | Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy |
title_fullStr | Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy |
title_full_unstemmed | Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy |
title_short | Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy |
title_sort | preoperative fibrinogen-albumin ratio index (fari) is a reliable prognosis and chemoradiotherapy sensitivity predictor in locally advanced rectal cancer patients undergoing radical surgery following neoadjuvant chemoradiotherapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505706/ https://www.ncbi.nlm.nih.gov/pubmed/32982448 http://dx.doi.org/10.2147/CMAR.S273065 |
work_keys_str_mv | AT lusiyi preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT liuzhenzhen preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT zhouxin preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT wangbingyan preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT lifei preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT mayanpeng preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT wangwendong preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT majunren preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT wangyuxia preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT wanghao preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy AT fuwei preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy |